Lowering the age for asymptomatic colon cancer screening from 50 to 45 suggests some important changes for physician practices. Joining us to talk about this change and more is Dr. Joseph Feuerstein, a gastroenterologist at Beth Israel Deaconess Medical Center in Boston, and an advisor for “Prevention and Early Detection of Colorectal Cancer: A Decision Support Tool,” previously developed through CRICO.